Ochiai Hirotaka, Shirasawa Takako, Yoshimoto Takahiko, Nagahama Satsue, Watanabe Akihiro, Sakamoto Ken, Kokaze Akatsuki
Department of Hygiene, Public Health and Preventive Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
All Japan Labor Welfare Foundation, 6-16-11 Hatanodai, Shinagawa-ku, Tokyo, 142-0064, Japan.
BMC Nephrol. 2020 Nov 10;21(1):471. doi: 10.1186/s12882-020-02144-6.
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) to ALT ratio (AST/ALT ratio) have been shown to be related to non-alcoholic fatty liver disease or insulin resistance, which was associated with chronic kidney disease (CKD). However, it is unclear whether ALT and AST/ALT ratio are associated with CKD. In this study, we examined the relationship of ALT and AST/ALT ratio to CKD among middle-aged females in Japan.
The present study included 29,133 women aged 40 to 64 years who had an annual health checkup in Japan during April 2013 to March 2014. Venous blood samples were collected to measure ALT, AST, gamma-glutamyltransferase (GGT), and creatinine levels. In accordance with previous studies, ALT > 40 U/L and GGT > 50 U/L were determined as elevated, AST/ALT ratio < 1 was regarded as low, and CKD was defined as estimated glomerular filtration rate < 60 mL/min/1.73 m and/or proteinuria. Logistic regression model was used to calculate the odds ratio (OR) and 95% confidence interval (CI) for CKD.
"Elevated ALT and elevated GGT" and "elevated ALT and non-elevated GGT" significantly increased the OR for CKD when compared with "non-elevated ALT and non-elevated GGT" (OR: 2.56, 95% CI: 2.10-3.12 and OR: 2.24, 95% CI: 1.81-2.77). Compared with "AST/ALT ratio ≥ 1 and non-elevated GGT", "AST/ALT ratio < 1 and elevated GGT" and "AST/ALT ratio < 1 and non-elevated GGT" significantly increased the OR for CKD (OR: 2.73, 95% CI: 2.36-3.15 and OR: 1.68, 95% CI: 1.52-1.87). These findings still remained after adjustment for confounders.
Elevated ALT was associated with CKD regardless of GGT elevation. Moreover, low AST/ALT ratio was also associated with CKD independent of GGT elevation.
丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶与ALT的比值(AST/ALT比值)已被证明与非酒精性脂肪性肝病或胰岛素抵抗有关,而这又与慢性肾脏病(CKD)相关。然而,尚不清楚ALT和AST/ALT比值是否与CKD有关。在本研究中,我们调查了日本中年女性中ALT和AST/ALT比值与CKD的关系。
本研究纳入了29133名年龄在40至64岁之间、于2013年4月至2014年3月期间在日本进行年度健康体检的女性。采集静脉血样本以检测ALT、AST、γ-谷氨酰转移酶(GGT)和肌酐水平。根据既往研究,ALT>40 U/L且GGT>50 U/L被判定为升高,AST/ALT比值<1被视为偏低,CKD被定义为估算肾小球滤过率<60 mL/min/1.73 m²和/或蛋白尿。采用逻辑回归模型计算CKD的比值比(OR)和95%置信区间(CI)。
与“ALT未升高且GGT未升高”相比,“ALT升高且GGT升高”以及“ALT升高且GGT未升高”显著增加了CKD的OR(OR:2.56,95%CI:2.10 - 3.12;OR:2.24,95%CI:1.81 - 2.77)。与“AST/ALT比值≥1且GGT未升高”相比,“AST/ALT比值<1且GGT升高”以及“AST/ALT比值<1且GGT未升高”显著增加了CKD的OR(OR:2.73,95%CI:2.36 - 3.15;OR:1.68,95%CI:1.52 - 1.87)。在对混杂因素进行校正后,这些结果仍然成立。
无论GGT是否升高,ALT升高均与CKD相关。此外,低AST/ALT比值也与CKD相关,且独立于GGT升高情况。